Splenectomy in two children with autoimmune lymphoproliferative syndrome and massive splenomegaly

Research output: Contribution to journalJournal articleResearchpeer-review

Treatment of patients with ALPS has varied but presently there is no consensus about the optimal therapy. Splenectomy is an option but data regarding the postsplenectomy outcome in pediatric ALPS patients remain very limited. We present two children who suffered from anemia and physical discomfort from the large spleen. Both patients underwent uneventful splenectomy and experienced significant improvement in cytopenia, daily activity and well-being. Furthermore the youngest patient showed a significant catch-up growth. We conclude that in selected patients with marked splenomegaly and ALPS, splenectomy may be considered a treatment option.
Original languageEnglish
JournalPediatric Blood & Cancer
Volume53
Issue number6
Pages (from-to)1124-6
Number of pages2
ISSN1545-5009
DOIs
Publication statusPublished - 2009

Bibliographical note

Keywords: Adolescent; Anemia, Hemolytic, Autoimmune; Female; Growth; Humans; Infant; Lymphoproliferative Disorders; Male; Splenectomy; Splenomegaly; Treatment Outcome

ID: 20072873